Following publication, concerns were raised about the duplicate submission of the article cited above in Experimental Biology and Medicine and BMC Gastroenterology. The article was published on 14 October 2023.
On 20 March 2024 the Editor in Chief of BMC Gastroenterology made the Editor in Chief of EBM aware that the article had been submitted to BMC on 14 March 2023. The article was rejected from BMC.
In line with the evidence of misconduct and the EBM dual submission policy, this article is retracted.
The authors received communication regarding the retraction but did not respond. This communication has been recorded by the publisher.
Summary
Keywords
Colorectal cancer, TRIM29, EZH2, migration, apoptosis
Citation
EBM Editorial Office (2024) Retraction: TRIM29 promotes the progression of colorectal cancer by suppressing EZH2 degradation. Exp. Biol. Med. 249:10243. doi: 10.3389/ebm.2024.10243
Received
16 May 2024
Accepted
16 May 2024
Published
10 June 2024
Volume
249 - 2024
Updates
Copyright
© 2024 EBM Editorial Office.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: EBM Editorial Office, ebm@ebm-journal.org
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.